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The susceptibility of multidrug resistant and biofilm 
forming Klebsiella pneumoniae and Escherichia 
coli to antiseptic agents used for preoperative skin 





Non-susceptibility of  bacteria to antiseptic agents used for preoperative skin preparations threaten the effectiveness of  prevention 
of  surgical site infections. Data concerning susceptibility of  multidrug resistant bacteria strains to antiseptic agents was limited at our 
setting. This study presents the susceptibility of  extended spectrum β-lactamases producing Klebsiella pneumoniae and Escherichia coli 
(with and without biofilm formation) to antiseptic agents used for preoperative skin preparations at zonal referral hospital in Mwanza, 
Tanzania.
Methods 
This cross-sectional descriptive study was conducted through July 2020. Presumptive extended spectrum beta-lactamase producing 
Klebsiella pneumoniae and Escherichia coli were recovered for this study. Disc combination method was used to confirm production of  
ESBL while tube method was used to detect biofilms formation. Then, isolates were tested for susceptibility towards 10% povidone 
iodine, 70% methylated spirit, 50% hydrogen peroxide (6% of  industrial H2O2 diluted in equal volume with sterile distilled water) and 
2% chlorhexidine. STATA software version 13.0 was used for data analysis. 
Results 
A total of  31 presumptive ESBL producers were recovered and phenotypically confirmed, whereas 54.8% (n=17) were K. pneumoniae 
and 45.2% (n=14) were E. coli. Five (35.7%) E. coli and seven (41.2%) K. pneumoniae had positive biofilms test results. Four (12.9%) 
bacteria were non-susceptible to antiseptic agents used for preoperative skin preparations. However, none exhibited resistance towards 
10% PVP-I. 
Conclusion 
In this study we highlight the existence of  multidrug resistant Gram-negative bacteria with resistance to antiseptic agents used for 
preoperative skin preparation at a zonal referral hospital in Mwanza, Tanzania.
Keywords: antiseptic agents; biofilms; extended spectrum beta-lactamases; Escherichia coli; Klebsiella pneumoniae; multidrug resistance; 
surgical site infections. 
Introduction
Antiseptics are substance that kills or inhibits the growth 
of  microorganism in or on the living tissue1,2. Antiseptics 
are used for different purposes including preoperative skin 
preparations and wounds irrigation postoperative procedures, 
depending on their strength, for the purpose of  prevention 
or management of  wound infections particularly surgical 
site infections (SSIs)2. Therefore, efficacious antiseptic 
agents with broad spectrum and bactericidal activities 
are recommended for preoperative skin preparations. 
Aqueous-based solutions (e.g., povidone-iodine (PVP-I) and 
chlorhexidine gluconate (CHG)) and alcohol-base solutions 
(e.g., ethyl and isopropyl alcohol) are commonly used in 
operating theatre rooms3. 
The emergence of  non-susceptible bacterial strains to 
antibiotics and antiseptic agents is reported worldwide4. 
Bacteria develops resistance when exposed to pressure 
from antibiotics and antiseptic agents contaminating 
environments5. It is also reported that, most bacterial strains 
exhibiting resistance to multiple antibiotics are also exhibiting 
resistance to certain antiseptic agents5. However, resistance 
to antiseptic agents can be organism’s natural property 
(intrinsic) which is mediated by impermeability, efflux, 
biofilms, and enzymatic degradation2,6. Organisms may 
also acquire resistance to antiseptics through chromosomal 
mutation or acquisition of  mobile genetic elements that 
harbour genes responsible for antiseptics resistance2,6. 
Klebsiella pneumoniae, Escherichia coli, Proteus species, Pseudomonas 
aeruginosa and Staphylococcus aureus are common bacteria 
exhibiting resistance to antiseptic agents2,6.  
Gadea et al, reported that 88.2% and 30.3% of  bacteria 
strains developed resistance to benzalkonium chlorine and 
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hexadecylpyridinium chloride respectively after exposure to 
quaternary ammonium compounds7. Study by Guimarães et 
al, reported that 52% and 38% of  antibiotic-multiresistant 
bacteria strains were non-susceptible to quaternary 
ammonium and phenol compounds respectively8. Non-
susceptibility of  bacteria to antiseptic agents threaten their 
effectiveness in prevention of  SSIs pre- and post-operations. 
In Mwanza, Tanzania, the incidence of  SSIs is ranging 
from 10.9% to 29.8% among patients with surgical acute 
abdomen, caesarean section and major surgeries9. Non-
susceptibility of  bacteria to antiseptic agents, among other 
factors, may be associated with SSIs at this setting. However, 
data concerning susceptibility of  multidrug resistant 
bacteria strains to antiseptic agents was limited. The first 
objective of  this study was to determine the magnitude of  
biofilm formation among extended spectrum β-lactamases 
producing E. coli (ESBL-EC) and K. pneumoniae (ESBL-KP). 
The second objective was to determine the susceptibility 
of  ESBL-EC and ESBL-KP (with and without biofilm 
formation) to antiseptic agents used for preoperative skin 
preparations at zonal referral hospital in Mwanza, Tanzania. 
Findings from this study provides baseline information to 
improve infections prevention and control (IPC) guidelines 
in operating theatres and surgical wards.  
Materials and Methods 
Study design, period, and setting 
This cross-sectional descriptive study was conducted 
through July 2020 in a Microbiology laboratory, a research, 
consultancy and teaching laboratory at Catholic University 
of  Health and Allied Sciences-Bugando (CUHAS-Bugando) 
affiliated in Bugando Medical Centre (BMC), Mwanza-
Tanzania. 
Antiseptic agents used for this study
Ten millilitre of  each antiseptic agent available in operating 
theatre rooms at BMC ready for use as preoperative skin 
preparation: 10% povidone iodine (10% PVP-I), 70% 
methylated spirit (70% MS), 50% hydrogen peroxide (50% 
H2O2; 6% of  industrial H2O2 diluted in equal volume with 
sterile distilled water) and 2% chlorhexidine (2% CHX) was 
collected in sterile, wide mouth and screw capped specimen 
containers. Specimens were brought to Microbiology 
laboratory at CUHAS-Bugando for analysis within 30 
minutes. 
Isolates selection and recovery 
Thirty five presumptive extended spectrum beta-lactamase 
(ESBL) producing Klebsiella pneumoniae (ESBL-KP) and 
Escherichia coli (ESBL-EC) stored in 20% glycerol in brain 
heart infusion broth (BHI; CM1135, Oxoid, UK) and 
archived at -80°C were selected and recovered for this study. 
Isolates were recovered by sub-culturing on plain plates of  
MacConkey agar (MCA; CM0109, Oxoid, UK) and then plates 
were incubated in ambient air at 37°C for 24 hours. Selected 
bacteria were previously isolated from rectal colonization 
in a study conducted in neonatal intensive care unit at 
Bugando Medical Centre in Mwanza, Tanzania. Originally, 
test bacteria were isolated on MacConkey agar plates which 
were supplemented with cefotaxime 2µg/ml for the purpose 
of  screening presumptive ESBL producing Gram-negative 
bacteria (resistant to third generation cephalosporins, 3GCs). 
Phenotypic confirmation of ESBL production
A disc combination method for confirmation of  ESBL 
production in E. coli and K. pneumoniae as reported in Clinical 
and Laboratory Standards Institute (CLSI) guidelines10 was 
used in this study. Bacteria were suspended in sterile normal 
saline 0.85% with turbidity equivalent to 0.5 McFarland 
standard solution and then plates of  Muller Hinton agar 
(MHA; CM0337, Oxoid, UK) were swabbed to make even 
lawns. Thereafter, within 15 minutes, ceftazidime 30µg discs 
(with and without clavulanic acid 10µg) were seeded and 
plates were incubated in ambient air at 37°C for 18-24 hours. 
Isolates with increased zone of  inhibition of  ≥5 mm of  
ceftazidime with clavulanic acid compared with ceftazidime 
without clavulanic acid was confirmed as ESBL producer. 
Detection of biofilm formation
Tube method as previous reported by Karigoudar et al.,11 was 
used for detection of  biofilm formation. A loopful (10µl) of  
test bacteria from overnight cultures were inoculated in 4 ml 
of  tryptic soy broth (TSB; Liofilchem, Italy) containing test 
tubes and then tubes were incubated aerobically at 37°C for 
24 hours. After 24 hours of  incubation, tubes were decanted, 
washed with phosphate buffer saline (PBS, pH 7.3) and 
allowed to dry in the inverted position at room temperature. 
The interior of  dried tubes were stained with crystal violet 
0.1% for 1 minute followed by washing with distilled water 
to remove excess stain and then dried in the inverted position 
at room temperature. Each isolate was tested in duplicate 
to confirm test results. Presence of  visible film lining the 
wall and bottom of  the tubes were interpreted as positive 
biofilm formation and absence of  visible film lining the wall 
and bottom of  the tubes were interpreted as negative biofilm 
formation (Figure 1).
Testing of susceptibility of bacteria to antiseptic 
agents 
Each strain of  bacteria was suspended in two test tubes 
containing sterile normal saline 0.85% ending with a turbidity 
equivalent to 0.5 McFarland measured by densimeter 
(DensiCHEK plus; BioMérieux, USA). Selection of  the 
strength of  suspension turbidity was based on the fact that, 
before application of  antiseptic agent(s) before operation, 
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the surface is cleaned with water and detergent. Cleaning 
minimizes the load of  both, resident and transient flora. 
Sterile cotton swabs (Improswab; Guangzhou, China) were 
dipped into suspension in each test tube and then swabbed 
on sterile (autoclaved at 121°C and 15lbs for 15 minutes) 
surface (a diameter of  3 cm) of  flat-bottom flask (Pyrex; 
Corning Inc, USA) and left for 10 minutes to contaminate 
the surface. Then, sterile absorbent gauze moistened with 
antiseptic agent for preoperative skin preparation was used 
to decontaminate the contaminated surface of  flat-bottom 
flask. To ensure effective decontamination, the area of  
coverage was extended to a diameter of  6 cm. Two sample 
swabs were collected by swabbing on decontaminated 
surface of  flat-bottom flask. Firstly, soon after antiseptic 
agent air dry and secondly, after 10 minutes from antiseptic 
agent air dry. We chose this method (surface contamination 
and decontamination) to mimic the procedure of  antiseptics 
application on living tissues. 
Swab samples were inoculated in 4 ml of  TSB as neutralizing 
agent and incubated for 4 hours at 37°C in ambient air. 
After 4 hours of  incubation, 10µL of  each inoculated TSB 
was quantitatively sub-cultured on plates of  5% sheep 
blood agar (Oxoid, UK) and then incubated aerobically for 
24 hours at 37°C. Bacteria strains on plates with positive 
cultures were quantified and identified to make sure the 
same contaminated bacteria strain is isolated. Biochemical 
identification of  isolates was done by using in-house 
prepared identification tests; TSI, SIM, Simmons citrate and 
urease agar. Identification of  similar isolate previously used 
to contaminate surface of  flat-bottom flask was interpreted 
as non-susceptibility to particular antiseptic agent used for 
decontamination. 
Data analysis 
STATA software version 13.0 was used for data analysis. 
Results are presented in percentages and fractions. PRTest 
was used to examine statistical difference between ESBL-KP 
and ESBL-EC or biofilms positive and negative in resisting 
antiseptic agents. 
Ethical considerations 
Methodologies of  this study were ethically cleared and 
approved by the joint BMC/CUHAS Ethics & Review 
Committee with certificate no: CREC 1503/2020. 
Permissions to conduct this study were sought from 
respective administrations of  Bugando Medical Centre 
(BMC) and Microbiology laboratory, Catholic University of  
Health and Allied Sciences-Bugando (CUHAS-Bugando). 
Results 
Isolates recovery and phenotypic confirmation of 
ESBL productions 
A total of  35 presumptive ESBL producing Gram-negative 
bacteria (20 K. pneumoniae and 15 E. coli) were recovered during 
this study period. Out of  35 presumptive ESBL producing 
Gram-negative bacteria, only 31; K. pneumoniae (85%, 17/20) 
and E. coli (93.3%, 14/15) were phenotypically confirmed 
to be ESBL producers by CLSI disc combination method. 
Table 1: Bacteria strains exhibiting non-susceptibility activity towards antiseptic agents
S/No Isolate Biofilm formation 2% CHX 10% PVP-I 50% H2O2 70% MS
AD 10 min AD 10 min AD 10 min AD 10 min
1 E. coli Positive + - - - - - - -
2 K. pneumoniae Negative - - - - - - + -
3 K. pneumoniae Negative - - - - + - - -
4 E. coli Positive + - - - - - + -
Figure 2: Percentages of phenotypically confirmed ESBL producing E. coli and K. pneumoniae and 
biofilm formation among ESBL-EC and ESBL-KP.
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Phenotypically confirmed ESBL producing E. coli and K. 
pneumoniae were further analyzed for biofilm formation and 
susceptibility to antiseptic agents. 
Biofilm formation 
Five (35.7%) out of  14 ESBL-EC and seven (41.2%) out of  
17 ESBL-KP were positive for biofilm formation on tube 
method. The difference between the magnitude of  biofilm 
formation of  ESBL-EC and ESBL-KP was not significant, 
p=0.847 (Table 1 and Figure 2). 
Susceptibility of test bacteria to antiseptic agents 
Four (12.9%) out of  31 ESBL producing Gram-negative 
bacteria were non-susceptible to antiseptic agents used for 
preoperative skin preparations. In general, the quantity of  
bacterial growth on recovery culture plates, as the level of  
resistance, ranged from 50 to 100 colonies. The overall 
resistance of  ESBL bacteria to individual antiseptic agent 
was 3.2% (1/31), 3.2% (1/31) and 6.4% (2/31) to 2% CHX, 
50% H2O2 and 70% MS, respectively. All bacteria strains 
(100%, n=4) showed resistance to antiseptic agents after 
air dry but not after exposure of  10 minutes. None of  the 
isolate tested exhibited resistance to 10% PVP-I (Table 1). 
We observed no significance difference between ESBL-KP 
and ESBL-EC (p=1.00) or positive and negative biofilm 
formation (p=1.00) in resistance to antiseptic agents.  
Discussion 
The main purpose of  antiseptic agents used before, during 
and after invasive procedures such as vein-punctures and 
minor or major surgeries is to minimize the risks of  endemic 
and epidemic healthcare associated infections (HCAIs)8. 
Surgical site infections (SSIs) and bloodstream infections 
(BSIs) are some examples of  HCAIs associated with 
ineffective use or the use of  substandard antiseptic agents12. 
A wide range of  antiseptic agents, aqueous- (e.g., povidone 
iodine and chlorhexidine gluconate) and alcohol-based (e.g., 
ethyl and isopropyl alcohol), are approved for clinical use 
in healthcare settings3. At their appropriate concentrations, 
standard antiseptic agents exhibit bactericidal activity against 
a wide range of  microorganisms13. 
The emergence and effective spreading of  antimicrobial 
resistance among Gram-negative bacteria particularly 
members of  the family Enterobacteriaceae threatens the 
effectiveness of  infectious diseases treatment. It is well 
established that, significant number of  bacteria with resistance 
to multiple antibiotics are also resistant to antiseptic agents5. 
At the current study’s setting, information on the magnitude 
of  extended spectrum β-lactamase producing Gram-negative 
bacteria (with and without biofilm production) resistant to 
antiseptic agents was limited. This study aimed at filling the 
existed gap. 
In this study, nearly one half  of  ESBL-KP were biofilm 
producers. This observation is similar to report by Nirwati 
et al.,14 who reported a prevalence of  49.1% of  biofilm 
production among clinically isolated MDR-K. pneumoniae. 
Contrarily to study by Olowe et al.,15 who reported a 
prevalence of  100% of  biofilm formation among MDR-E. 
coli, in our study we observed that, about one third of  ESBL-
EC were biofilm producers. The difference of  magnitude of  
biofilm formation among strains of  E. coli from study by 
Olowe et al., and our study could be due to different level of  
resistance between E. coli strains used in the two studies. As 
Olowe et al., used MDR E. coli strains (resistant to multiple 
antibiotics of  different chemical structures, and site and 
mechanisms of  actions) while in our study we used ESBL 
E. coli strains (resistant to β-lactams). Biofilm forming MDR 
bacteria are associated with resistance to multiple antibiotics 
compared to their counter-parts. Therefore, increasing the 
risk of  patients’ treatment complications including treatment 
failure then increased mortality. 
In consistence to previous studies16,17, this current study 
also reports non-susceptibility (12.9%) of  ESBL producing 
Gram-negative bacteria (with and without biofilm formation) 
to antiseptic agents commonly used as preoperative skin 
preparations; 2% CHX, 50% H2O2 and 70% MS at our 
setting. Chen et al.,16 reported a reduced susceptibility of  
carbapenemases producing K. pneumoniae and E. coli to 
0.1% CHX by MIC90 32mg/L and 16mg/L respectively. 
In the study by Chen et al., all of  the isolates (100%) tested 
had reduced susceptibility to antiseptic agents while in 
our study about one in ten (12.9%) of  the isolates tested 
exhibited resistance to antiseptic agents. This difference 
could be because, not only Chen et al., used bacteria strains 
with superior resistance mechanisms (carbapenemases 
production) to ours (ESBLs producers) but also they used 
low concentrations of  antiseptic agents compared to ours. 
Another study by Liu et al., reported a reduced susceptibility 
of  all carbapenems resistant Acinetobacter baumannii tested to 
CHX ranging from 4 to 64 µg l−1 18.
Although Liu et al., used known carbapenems resistant 
strains of  Acinetobacter baumannii a bacterium known with 
its general innate low susceptibility to multiple antibiotics 
and antiseptics19 as compared to bacteria strains used in 
our study. Therefore explaining the highest magnitude of  
resistance observed in a study by Liu et al., compared to our 
study. 
Similarly to reports by Cochran et al.,20 and Perumal et al.,21 we 
also observed non-susceptibility of  tested bacteria to 50% 
H2O2. But, Cochran et al., and Perumal et al., demonstrated 
an increased reduced susceptibility among biofilm forming 
cells than planktonic cells while we observed resistance to 
50% H2O2 among planktonic cells of  ESBL-KP. Although 
biofilm formation is known to increase resistance to antiseptic 
agents, the planktonic cells of  ESBL-KP in our study 
may have had acquired another mechanism of  resistance 
towards H2O2. In alignment to a study by Awodele et al.,
22 
we observed non-susceptibility of  ESBL-EC (with positive 
biofilms) and ESBL-KP (with negative biofilms) to 70% MS. 
However, Awodele et al., observed resistance at 50% MS but 
not at 100% MS. A review by Bigliardi et al.,23 reported weak 
bactericidal activity of  alcohol-based antiseptic particularly 
70% ethanol towards Gram-negative bacteria.  
From our findings, the presence of  ESBL producing Gram-
negative bacteria (with and without biofilm production) 
resistant to antiseptic agents used for preoperative skin 
preparations, suggest a possible source of  SSIs at this setting. 
A surveillance by Moremi et al., reported a prevalence of  
14.6% SSIs at the same region24. However, that surveillance 
found no proof  of  hospital’s water plumbing system and 
rectal carriage playing the role of  transmission24. Therefore, 
pointing to another sources that may include strains of  
bacteria colonizing or contaminating at incision site which 
are resistant to antiseptic agents used for preoperative skin 
preparation and postoperative surgical site dressing. 
In this study we observed no bacteria with resistance to 10% 
PVP-I. This observation align with a review by Bigliardi et 
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al., that PVP-I lack resistance and it is efficacious against 
biofilms23. PVP-I is considered the most effective antiseptic 
agent as it has the broadest spectrum of  antimicrobial activity 
compared to other available antiseptic agents25,26. Therefore, 
10% PVP-I may be considered as first-choice antiseptic 
agent at our setting as long as prevention and treatment of  
SSIs is concerned, as reported previous25. 
Moreover, we observed that, all ESBL-KP and ESBL-EC 
with and without biofilms with resistance to antiseptic 
agents, exhibited resistance only after antiseptic agent air 
dry but not after a 10 minutes exposure. Increased exposure 
time, significantly increases antimicrobial activity of  a 
particular antiseptic agent25. For example, with increased 
exposure time, PVP-I is said to exhibit activity against spores 
and some viruses including influenza virus25,27. Therefore, 
increasing time of  exposure for an antiseptic agent for a 
better outcome is mandatory.  
Conclusion 
In this study we highlight the existence of  multidrug 
resistant Gram-negative bacteria (with and without 
biofilms) exhibiting resistance to antiseptic agents used for 
preoperative skin preparation at a zonal referral hospital in 
Mwanza, Tanzania. We recommend further studies to explore 
the direct association between antiseptics resistant bacteria 
and the incidence of  SSIs at our setting. We also recommend 
molecular studies to determine antiseptic resistance genes 
circulating among clinical and environmental isolates in our 
setting. 
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